期刊文献+

Notch-1和微小RNA-200家族在胰腺癌上皮-间充质转化中的作用 被引量:3

The mechanisms of Notch - 1 and microRNA - 200 family in epithelial - mesenchymal transition of pancreatic cancer
原文传递
导出
摘要 目的观察Noteh-1和微小RNA(miRNA,miR)-200家族在吉西他滨(Gem)诱导的人胰腺癌PANC-1细胞上皮-间充质转化(EMT)中的作用。方法体外培养PANC-1细胞并诱导细胞EMT,Western blot实验和反转录.聚合酶链反应(RT-PCR)检测Notch—1、E-钙黏蛋白(E-cadherin)、波形蛋白(Vimentin)、相关转录因子及miR-200家族成员的表达;Transwell小室检测具有EMT改变的PANC-1细胞迁移和侵袭能力。结果Gem诱导PANC-1细胞EMT最适药物浓度为10nmol/L,最适时间为9d。Western blot灰度分析显示未经Gem处理的亲代细胞(parental)组Noteh-1、E—cadherin、Vimentin、slug、snail、twist、E盒结合锌指蛋白1(ZEBl)的表达分别为0.840±0.002、0.995±0.008、1.158±0.001、0.253±0.004、0.528±0.003、0.346±0.002,0.29l±0.006,Gem(+)组分另0为1.599±0.00l、0.483±0.001、1.821±0.003、0.719±0.004、0.919±0.005、0.762±0.002、0.70l±0.004,两组比较差异有统计学意义(P〈0.05)。RT—PCR检测parental组Notch-1、E—cadherin、Vimentin、slug、snail、twist、ZEB1 mRNA的表达分别为(2.200±0.010)×10-3、(1.540±0.002)×10-4、1.003±0.004、(8.580±0.003)×10-4、(5.040±0.007)×10-3、(6.930±0.001)×10-5、(2.010±0.001)×10-4,Gem(+)组分别为(5.870±0.004)×10-5、(1.430±0.001)×10-5、1.660±0.007、(4.030±0.002)×10-3、(8.980±0.005)×10-3、(3.300±0.020)×10-6、(1.120±0.003)×10-3,两组比较差异有统计学意义(P〈0.05)。RT—PCR法检测parental组miR-200a、miR-200b、miR-200e、miR-141和miR-429的表达水平分别为(2.340±0.002)×10-5、(4.280±0.001)×10-6、(3.250±0.003)×10-5、(2.470±0.004)×10-5、(6.230±0.005)×10-4,Cem(+)组分别为(0.801±0.000)×10-5、(2.030±0.004)×10-6、(5.000±0.050)×10-6、(3.670±0.003)×10-6、(1.310±0.002)×10-4,两组问比较差异有统计学意义(P〈0.05)。PANC-1细胞EMT改变后侵袭能力明显增强,parental组迁移和侵袭实验细胞计数分别为(25.70±3.67)个和(16.30±2.21)个,Gem(+)组分别为(77.40±3.01)个和(68.00±8.76)个,两组间比较差异有统计学意义(P〈0.05)。结论Gem可诱导PANC-1细胞EMT,Noteh-1可能是该过程的重要信号通路,并参与miR-200家族的调控。 Objective To investigate the mechanisms of Notch - 1 and microRNA (miRNA, miR) -200 family in epithelial- mesenehymal transition (EMT) induced by gemcitabine (Gem). Meth- ods EMT phenotype of PANC - 1 cells was induced by Gem, as well as the expression of Notch - 1, E - cadherin, Vimentin, relevant transcription factors, and miR - 200 family were observed by Western blotting and reverse transcriptasc - polymerase chain reaction ( RT - PCR). Migration and invasion abilities were detected by transwell assay. Results The most appropriate drug concentration for EMT was 10 nmol/L, and the suitable time was 9 days. Western blotting analysis showed that the expression of Notch - 1, E - cadherin, Vimentin, slug, snail, twist, zinc finger E -box binding protein 1 (ZEB1) in parental group were 0. 840 ± 0.002,0.995 ±0.008, 1.158 ±0.001, 0.253±0.004, 0.528 ±0.003, 0.346 ±0.002, 0.291 ± 0. 006, and the Gem( + ) group were 1. 599 ±0. 001, 0. 483 ±0. 001, 1. 821 ±0. 003, 0. 719 ±0. 004, 0. 919 ±0. 005, 0. 762 ± 0. 002, 0. 701± 0. 004, there was significant difference between the two group (P 〈0. 05). RT - PCR analysis of the mRNA of Notch - 1 , E - cadherin, Vimentin, slug, snail, twist,ZEB1 in parental group were (2.200 ±0.010) × 10-5, (1.540 ±0.002) × 10-4, 1.003 ±0.004, (8.580±0.003) × 10-4, (5.040 +0.007) x 10-3, (6.930 ±0.001) × 10-5, (2.010 ±0.001) × 10-4, and the Gem(+) were (5. 870 +0.004) × 10-5, (1.430±0.001) × 10-5, 1.660 ±0.007, (4.030 ±0.002) ×10-3, (8.980 ±0.005) x10-3, (3.300+0.020) ×10-4, (1.120±0.003) ×10-3, there was significant difference between the two group ( P 〈 0. 05 ). RT - PCR analysis of miR - 200a, miR -200b, miR -200c, miR - 141 and miR -429 were (2. 340+0. 002) × 10-5, (4. 280±0. 001 ) × 10-6, (3.250±0.003) ×10 5, (2.470±0.004) ×10-5, (6.230±0.005) ×10-4, and Gem (+) group were (0.801±0.000) ×10-5, (2.030±0.004) ×10-6, (5.000±0.050) ×10-6, (3.670± 0. 003) x 10-6, ( 1. 310 ± 0. 002) × 10-4, there was significant difference between the two group ( P 〈 0. 05 ). The migration and invasion abilities of gemcitabine resistance cells were enhanced. The cell content found that the parental group of Transwell migration and invasion assay were 25.70± 3.67, 16. 30 ± 2. 21, and the Gem ( + ) group were 77.40 ± 3.01 , 68.00 ± 8.76, there was significant difference between the two group( P 〈 0. 05 ). Coneluslon Gem was a critical drug for EMT phenotype of PANC - 1 cells. Notch - 1 signaling pathway may be mechanistically linked with EMT phenotype and the regulation of miR - 200 family.
出处 《中华实验外科杂志》 CAS CSCD 北大核心 2016年第7期1792-1796,共5页 Chinese Journal of Experimental Surgery
基金 国家自然科学基金(81272693)
关键词 胰腺癌 上皮.间充质转化 Notch-1信号通路 微小RNA-200家族 Pancreatic cancer Epithelial - mesenehymal transition Notch - 1 signaling path- way MicroRNA - 200 family
  • 相关文献

参考文献23

  • 1Siegel R, Ward E, Brawly O,et al. Cancer statistics ,2011 :The impact of eliminating socioeconomic and racial disparities on premature canc- er deaths[ J]. CA Cancer J Clin,2011,61 (4) :212-236. DOI : 10. 3322/caac. 20121.
  • 2Niedcrhuber JE, Brennan MF, Menck HR. The national cancer data base report on pancreatic cancer [ J ]. Cancer, 1995,76 ( 9 ) : 1671 - 1677. DOI: 10. 1002/109743142 ( 19951101 ) 76:9 < 1671:: AID- CNCR2820760926 >3.0. CO;2-R.
  • 3Sultana A, Smith CT, Cunningham D, et al. Meta-analyses of chemo- therapy for locally advanced and metastatic pancreatic cancer [ J ]. J Clin Onco1,2007,25 ( 18 ) :2607-2615.
  • 4Wilkowski R, Wolf M, Heinemann V. Primary advanced unresectable pancreatic cancer[ J ]. Recent Results Cancer Res ,2008 ,177 :79-93.
  • 5Li QQ, Xu JD, Wang WJ, et al. Twistl-mediated adrlamycin-induced epithelial-mesenchymal transition relates to muhidrug resistance and invasive potential in breast cancer cells [ J ]. Clin Cancer Res, 2009, 15 ( 8 ) :2657-2665. DOI : 10.1158/107843432. CCR-08-2372.
  • 6Liu L, Zhang J, Yang X, et al. SALL4 as an epithelial-mesenchymal transition and drug resistance inducer through the regulation of c-Myc in endometrial cancer[ J]. PLoS One,2015,10(9) :e0138515. DOI: 10.1371/journal. pone. 0138515.
  • 7Sahlgren C, Gustafsson MV ,Jin S, et al. Notch signaling mediates hy- poxia-induced tumor cell migration and invasion [ J ]. Proc Natl Acad Sci U S A ,2008,105 ( 17 ) :6392-6397. DOI : 10. 1073/pnas. 0802047105.
  • 8Xue X, Zhang Y, Zhi Q, et al. MiR200-upregulated vasohibin 2 pro-motes the malignant transformation of tumors by inducing epithelial- mesenchymal transition in hepatocellular carcinoma[ J ]. Cell Commun Signal ,2014,12:62. DOI : 10.1186/s12964-O14-O062-x.
  • 9Colucci G, Giuliani F, Gebbia V, et al. Gemcitabine alone or with cis- platin for the treatment of patients with locally advanced and/or meta- static pancreatic carcinoma:a prospective,randomized phase III study of the Gruppo Oncologia dell' Italia Meridionale [J]. Cancer,2002,94 (4) :902-910. DOI:10. 1002/cncr. 10323. abs.
  • 10Singh A,Settleman J. EMT,cancer stem cells and drug resistance:an emerging axis of evil in the war on cancer [J]. Oncogene, 2010,29 (34) :4741-4751. DOI : 10. 1038/onc. 2010. 215.

同被引文献21

引证文献3

二级引证文献18

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部